There are 12 new IPOs this week, a sign that numerous companies were waiting until after the massive Alibaba Group Holding Ltd. (Nasdaq: BABA) IPO to hold initial public offerings of their own.
The Alibaba IPO took place on Friday, Sept. 19, and in the month prior to the deal there were only six IPOs. In the two following weeks, the IPO calendar has seen 21 IPOs.
This week, the largest offering is the $1 billion deal of Fairmount Santrol (NYSE: FMSA) which will begin trading on Friday. But that's not this week's only large deal. The rest of this week's deals are expected to raise a combined $2.2 billion.
Here are each of this week's 12 new IPOs and the details behind each deal...
Fairmount Santrol (NYSE: FMSA) provides oil and gas companies with sand and sand-based products. FMSA will be the biggest of this week's new IPOs as the company looks to raise $1 billion. Fairmount will be offering 44.5 million shares at a range $21 to $24 per share. In the last year, FMSA had revenue of $1.2 billion, and the company is expected to have a valuation of $4 billion. FMSA is expected to begin trading on the New York Stock Exchange on Friday, Oct. 3.
VWR Corp. (Nasdaq: VWR) is a supplier of general and specialty laboratory equipment to life science and general research companies. Through its IPO, VWR is looking to raise $600 million by offering 25.5 million shares at a $22 to $25 range. VWR is expected to have a market value of $3 billion, and the company had $4.3 billion in revenue last year. Shares of VWR will hit the market on Thursday, Oct. 2.
Vivint Solar Inc. (NYSE: VSLR) is a provider of residential solar energy systems and is a spin-off of the Blackstone Group. Through the initial public offering, VSLR is looking to raise $350 million by selling 20.6 million shares at a range of $16 to $18. In the last year, VSLR had revenue of $14 million. Following the IPO, VSLR should have a market cap of roughly $1.9 billion. VSLR stock will begin trading on the NYSE on Wednesday, Oct. 1.
Money Morning Members: Continue reading for the rest of this week's 12 new IPOs...
Atento S.A. (NYSE: ATTO) is the largest provider of business process outsourcing services in Latin America and Spain. Through the IPO, ATTO is looking to raise $300 million by selling 14.6 million shares at a price range of $19 to $22. Following the deal, ATTO should have a market valuation of $1.5 billion. In the last year, ATTO had $2.3 billion in revenue, and the stock will begin trading on the NYSE on Thursday, Oct. 2.
Wayfair (Nasdaq: W) is looking to raise $292 million through its IPO by selling 11 million shares at a $25 to $28 range. Wayfair is an online retailer of home furnishings that had more than $1.1 billion in revenue last year. Following this week's IPO, Wayfair should have a market cap of roughly $2.3 billion. W stock will begin trading on Nasdaq on Thursday Oct. 2.
JP Energy Partners LP (NYSE: JPEP) plans to raise $275 million by offering 13.8 million shares at a $19 to $21 range. JPEP will hit the New York Stock Exchange on Thursday, Oct. 2.
Calithera Biosceinces Inc. (Nasdaq: CALA) is looking to raise $84 million by selling 6 million shares at a range of $13 to $15 each. CALA will begin trading on Thursday, Oct. 2.
Dermira Inc. (Nasdaq: DERM) is aiming to raise $80 million by selling 5.4 million at a $14 to $16 range. DERM stock will make its debut on Friday, Oct. 3.
Yodlee Inc. (Nasdaq: YDLE) plans to raise $75 million by offering 6.3 million shares at an $11 to $13 range. YDLE will hit the market on Friday, Oct. 3.
American Addiction Centers Holdings (NYSE: AAC) is looking to raise $65 million by offering 5 million shares at a range of $12 to $14. AAC will begin trading on the NYSE on Thursday, Oct. 2.
DT Asia Investments Ltd. (Nasdaq: CADTU) is looking to raise $60 million by offering 6 million shares for $10 each. CADTU is expected to begin trading on Tuesday, Sept. 30.
EyeGate Pharmaceuticals Inc. (Nasdaq: EYEG) wants to raise $25 million by selling 1.9 million shares at a $12 to $14 range. EYEG will hit the Nasdaq on Friday, Oct. 3.
NOW: Here's what rising interest rates really do to your shares. What you've been hearing from the pundits is all wrong...
[epom]